MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
HIV/AIDS drug development and treatment
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,576 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,576 works in the cohort · of 4,299,418page 2 of 32

Labels cover 3 of 1,576 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,576 of 1,576 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

afffundunlabeled
End-Stage Renal Disease Among HIV-Infected Adults in North America
Alison G. Abraham, Yuezhou Jing, Michelle M. Estrella, C. William Wester, Heidi M. Crane, Joseph J. Eron +63 more
2014· article· en· Clinical Infectious Diseases· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
172
citations
affunlabeled
Dolutegravir in antiretroviral-naive adults with HIV-1
Hans-Jürgen Stellbrink, Jacques Reynes, Adriano Lazzarin, Eugene Voronin, Federico Pulido, Franco Felizarta +4 more
2013· article· en· AIDS· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
163
citations
affno abstractunlabeled
The nephrotoxic effects of HAART
Hassane Izzedine, Marianne Harris, Mark A. Perazella
2009· review· en· Nature Reviews Nephrology· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
141
citations
affunlabeled
Patient-Reported Nonadherence to HAART Is Related to Protease Inhibitor Levels
Rita Murri, Adriana Ammassari, Keith Gallicano, Andrea De Luca, Antonella Cingolani, Denise L. Jacobson +2 more
2000· article· en· JAIDS Journal of Acquired Immune Deficiency Syndromes· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · insufficient_payload
140
citations
affunlabeled
Efficacy and Safety of Switching to Dolutegravir/Lamivudine Versus Continuing a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen for Maintenance of Virologic Suppression in Adults Living With Human Immunodeficiency Virus Type 1: Results Through Week 144 From the Phase 3, Noninferiority TANGO Randomized Trial
Olayemi Osiyemi, Stéphane De Wit, Faïza Ajana, Fiona Bisshop, Joaquín Portilla, Jean Pierre Routy +11 more
2022· article· en· Clinical Infectious Diseases· Medicine
distilled prediction:candidate · noneconsensus · none
137
citations

How this was built: Screen · Findings · About